Mometasone Aristo (Mometasone Furoate Ph. Eur.)

Mometasone furoate, the active ingredient in Mometasone Aristo, is a potent glucocorticoid corticosteroid presented as a nasal spray for intranasal administration. It reduces nasal inflammation and congestion associated with allergic rhinitis, including both seasonal and perennial types, in adults and children.

GNH USA supplies Mometasone Aristo as a licensed, GMP‑compliant pharmaceutical product, providing reliable international distribution to hospitals, pharmacies and clinics worldwide, with full adherence to Good Distribution Practice and regulatory standards, and ensuring product integrity throughout the supply chain.

Mometasone furoate nasal spray is used to treat inflammatory conditions of the nasal passages, primarily allergic rhinitis. - Allergic rhinitis: relief of nasal congestion, itching, sneezing and rhinorrhea. - Seasonal allergic rhinitis: control of symptoms during pollen or mold seasons. - Perennial allergic rhinitis: reduction of year‑round nasal inflammation and mucus production.

Adverse reactions are generally localized to the nasal cavity, but systemic effects can occur with excessive use.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleeds). - Throat irritation or dryness. - Cough. - Altered taste or bitter taste.

Serious or Rare Side Effects: - Nasal septal perforation. - Severe allergic reaction (anaphylaxis). - Vision changes such as cataracts or glaucoma. - Adrenal suppression with prolonged high‑dose use. - Opportunistic fungal infection of the nasal passages.

Before initiating therapy, consider the following safety measures. - Assess for active nasal infections: avoid use until infection resolved. - Hypersensitivity: discontinue if patient shows allergy to mometasone or other steroids. - Use the lowest effective dose to minimize systemic exposure. - Monitor for signs of systemic glucocorticoid effects, especially with long‑term use. - Caution in patients with uncontrolled diabetes or hypertension. - Store at room temperature: keep in the original container, protect from moisture and heat.

Mometasone nasal spray may interact with other medications; awareness of interaction severity helps guide clinical decisions.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase systemic corticosteroid exposure. - Concurrent systemic corticosteroids can amplify adrenal suppression risk. - Live vaccines may have reduced efficacy when used with intranasal steroids.

Moderate Interactions (Monitor Closely): - Other intranasal decongestants may increase local irritation. - Oral antihistamines may add to sedation if they have sedating properties. - Immunosuppressants may raise infection susceptibility. - Antifungal nasal preparations may alter local flora. - Nasal antihistamine sprays may affect absorption of mometasone.